• Home
  • Search Results

Search Results

Open
Young Adult (18-34)
364 studies match your search
Open

Basal-like PDAC treated with Gemcitabine, Erlotinib and nab-paclitaxel (PANGEA).

Are you a patient with advanced basal-like pancreatic adenocarcinoma? If so this could the a Trial for you to as this is a Phase I/II trial is to evaluate the safety, efficacy and tolerability of low-dose EGFR inhibitors in combination with bi-weekly gemcitabine/nab-paclitaxel (GnP) in subjects with basal tumors

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Pancreatic)
Open

Suicidality in Adolescents Following Psychiatric Hospitalization

Is your child being hospitalized at UNC Youth Behavioral Health for suicidal thoughts or behaviors? If so, you may be eligible to participate in a research study to identify the risk factors associated with recurrence of suicidal thoughts after psychiatric hospitalization. Both you and your child must participate to be eligible for the research study. Compensation provided.

Age & Gender
  • 12 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Child and Teen Health
  • Mental and Emotional Health
  • Parents of Children
  • and 2 more
Visit Location
100% Remote (online, phone, text)
Open

First in Human Study of IMGN151 in adut patients with Recurrent Endometrial Cancer and Recurrent, High-Grade Serous Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers.

Do you have Recurrent endometrial cancer,Recurrent, high-grade serous epithelial ovarian, primary peritoneal, or fallopian tube cancer that has progressed during or after standard treatments? If so, you may be able to take part in a research study looking at the safety of giving a treatment of test drug IMGN151-1001 to patients with these types of cancer

Age & Gender
  • 18 years ~ 99 years
  • Female
Study Interest
  • Cancer (Uterine (endometrial), Ovarian)
Open

Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission

Have you been diagnosed with aggressive B-cell lymphomas and received CAR-T treatment? If so, you may be able to take part in a research study. This study is looking at the efficacy of giving an investigational drug called Epcoritamab in comparison with no treatment. The participants should have received CAR-T treatment but did not have complete remission.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Glands and Hormones
Open

A PHASE 1/2A, OPEN-LABEL, DOSE-ESCALATION AND DOSE-EXPANSION FIRST-IN-HUMAN STUDY OF THE SAFETY, TOLERABILITY, ACTIVITY, AND PHARMACOKINETICS OF REGN10597 (ANTI PD-1-IL2RA-IL2 FUSION PROTEIN) IN PATIENTS WITH ADVANCED SOLID ORGAN MALIGNANCIES

Do you have kidney or bladder cancer. You may be able to participate in a research study to find out if the investigational drug REGN10597 is safe, tolerable, and effective in treating kidney and bladder cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Bladder, Kidney)
Open

Teens, Emotions, and Social Interactions Study

Are you the parent of a female 13-15 year old teen? Do you have a history of depression? If so, you and your teen may be able to participate in a study looking at teenager's brain responses, emotions, social interactions, and depression risk. Families can be paid up to $375 for their participation in the study.

Age & Gender
  • 13 years ~ 99 years
  • Female, Gender Inclusive
Study Interest
  • Child and Teen Health
  • Healthy Volunteer or General Population
  • Parents of Children
Open

MODERN

Do you have bladder cancer that has spread to nearby tissue or other parts of the body? You may be able to participate in a research study to find out if the investigational drug disitamab vedotin alone or with pembrolizumab works to treat bladder cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Bladder)
Open

Bladder Cancer Study

Do you have bladder cancer and have had your bladder removed? If so, you may be able to take part in a research study to determine if patients need additional treatment called immunotherapy to prevent cancer from coming back.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Bladder)
Open

Targeted lifestyle change (TLC) group prenatal care for women at high risk for gestational diabetes

Do you want to experience a nurturing, empowering and wellness-centered prenatal care that helps you reduce the chance of getting diabetes in pregnancy? Then the Targeted Lifestyle Change (TLC) Study might be for you! TLC is specially designed to help you learn how to eat, move, and live for two during pregnancy to explore whether we can reduce the risks of diabetes in pregnancy. Compensation provided.

Age & Gender
  • 0 days ~ 45 years
  • Female, Gender Inclusive
Study Interest
  • Diabetes
  • Pregnancy
  • Women's Health
  • and 2 more
Open

OCD in African Americans Study

Have you ever noticed yourself repeatedly thinking or doing specific things? Have you experienced symptoms of OCD now or in the past (even if you did not seek treatment)? Do you identify as Black? If you have (or think you might have) OCD, you may be able to participate in a study to learn more about OCD and new methods for prevention and treatment. Participants will receive $50.

Age & Gender
  • 8 years ~ 89 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Healthy Volunteer or General Population
  • Minority Health
  • and 3 more
Visit Location
100% Remote (online, phone, text)
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research